{"nct_id":"NCT03650452","title":"A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of TAK-935 (OV935) as an Adjunctive Therapy in Pediatric Participants With Developmental and/or Epileptic Encephalopathies","status":"COMPLETED","status_verified_date":"2021-01","start_date":"2018-08-08","start_date_type":"ACTUAL","primary_completion_date":"2020-06-09","primary_completion_date_type":"ACTUAL","completion_date":"2020-07-20","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["TAK"]}